These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8036180)

  • 1. Induction of apoptosis in androgen-independent human prostate cancer cells undergoing thymineless death.
    Kyprianou N; Bains AK; Jacobs SC
    Prostate; 1994 Aug; 25(2):66-75. PubMed ID: 8036180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Thymineless" death in androgen-independent prostatic cancer cells.
    Kyprianou N; Isaacs JT
    Biochem Biophys Res Commun; 1989 Nov; 165(1):73-81. PubMed ID: 2531584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.
    Kyprianou N; English HF; Isaacs JT
    Cancer Res; 1990 Jun; 50(12):3748-53. PubMed ID: 2340521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468.
    Armstrong DK; Isaacs JT; Ottaviano YL; Davidson NE
    Cancer Res; 1992 Jun; 52(12):3418-24. PubMed ID: 1534511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis.
    Sklar GN; Eddy HA; Jacobs SC; Kyprianou N
    J Urol; 1993 Nov; 150(5 Pt 1):1526-32. PubMed ID: 8411447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis: therapeutic significance in the treatment of androgen-dependent and androgen-independent prostate cancer.
    Kyprianou N
    World J Urol; 1994; 12(6):299-303. PubMed ID: 7881465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism and role of growth arrest in programmed (apoptotic) death of prostatic cancer cells induced by thapsigargin.
    Lin XS; Denmeade SR; Cisek L; Isaacs JT
    Prostate; 1997 Nov; 33(3):201-7. PubMed ID: 9365549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed death of nonproliferating androgen-independent prostatic cancer cells.
    Martikainen P; Kyprianou N; Tucker RW; Isaacs JT
    Cancer Res; 1991 Sep; 51(17):4693-700. PubMed ID: 1873814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in an androgen-independent mouse cell line by transforming growth factor-beta 1.
    Furuya Y; Ohta S; Shimazaki J
    J Exp Ther Oncol; 1996 Nov; 1(6):377-84. PubMed ID: 9414428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction.
    Furuya Y; Lin XS; Walsh JC; Nelson WG; Isaacs JT
    Endocrinology; 1995 May; 136(5):1898-906. PubMed ID: 7720636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-induced apoptosis of human prostate cancer cells is independent of mutant p53 overexpression.
    Kyprianou N; Rock S
    Anticancer Res; 1998; 18(2A):897-905. PubMed ID: 9615738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer.
    Denmeade SR; Lin XS; Isaacs JT
    Prostate; 1996 Apr; 28(4):251-65. PubMed ID: 8602401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation.
    Kyprianou N; English HF; Davidson NE; Isaacs JT
    Cancer Res; 1991 Jan; 51(1):162-6. PubMed ID: 1899037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells.
    Robertson CN; Roberson KM; Padilla GM; O'Brien ET; Cook JM; Kim CS; Fine RL
    J Natl Cancer Inst; 1996 Jul; 88(13):908-17. PubMed ID: 8656443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
    Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H
    Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abrogation of heat-shock protein (HSP)70 expression induced cell growth inhibition and apoptosis in human androgen-independent prostate cancer cell line PC-3m.
    Zhao ZG; Ma QZ; Xu CX
    Asian J Androl; 2004 Dec; 6(4):319-24. PubMed ID: 15546023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.
    Bang YJ; Kim SJ; Danielpour D; O'Reilly MA; Kim KY; Myers CE; Trepel JB
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3556-60. PubMed ID: 1373503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells.
    Kyprianou N; King ED; Bradbury D; Rhee JG
    Int J Cancer; 1997 Jan; 70(3):341-8. PubMed ID: 9033638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis in androgen-independent mouse mammary tumor cells induced by 5-fluorodeoxyuridine but not by androgen withdrawal.
    Furuya Y; Shimazaki J
    Anticancer Res; 1996; 16(5A):2613-8. PubMed ID: 8917359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
    Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.